ATE473282T1 - Methoden und zusammensetzungen für die produktion von viruspartikeln - Google Patents

Methoden und zusammensetzungen für die produktion von viruspartikeln

Info

Publication number
ATE473282T1
ATE473282T1 AT99920883T AT99920883T ATE473282T1 AT E473282 T1 ATE473282 T1 AT E473282T1 AT 99920883 T AT99920883 T AT 99920883T AT 99920883 T AT99920883 T AT 99920883T AT E473282 T1 ATE473282 T1 AT E473282T1
Authority
AT
Austria
Prior art keywords
methods
compositions
production
virus particles
retroviral
Prior art date
Application number
AT99920883T
Other languages
English (en)
Inventor
Christophe Torrent
Patrice Yeh
Michel Perricaudet
David Klatzmann
Jean-Loup Salzmann
Original Assignee
Aventis Pharma Sa
Genopoietic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Genopoietic filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE473282T1 publication Critical patent/ATE473282T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
AT99920883T 1998-05-18 1999-05-18 Methoden und zusammensetzungen für die produktion von viruspartikeln ATE473282T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806258A FR2778670B1 (fr) 1998-05-18 1998-05-18 Methodes et compositions pour la production de particules virales
PCT/FR1999/001184 WO1999060144A1 (fr) 1998-05-18 1999-05-18 Methodes et compositions pour la production de particules virales

Publications (1)

Publication Number Publication Date
ATE473282T1 true ATE473282T1 (de) 2010-07-15

Family

ID=9526464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920883T ATE473282T1 (de) 1998-05-18 1999-05-18 Methoden und zusammensetzungen für die produktion von viruspartikeln

Country Status (10)

Country Link
US (1) US6489142B1 (de)
EP (1) EP1078094B1 (de)
JP (1) JP2002539758A (de)
AT (1) ATE473282T1 (de)
AU (1) AU762973B2 (de)
CA (1) CA2332639A1 (de)
DE (1) DE69942564D1 (de)
FR (1) FR2778670B1 (de)
NZ (1) NZ508791A (de)
WO (1) WO1999060144A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018240A1 (en) * 1998-10-01 2000-04-06 University Of Southern California Gene delivery system and methods of use
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
EP1201750A1 (de) * 2000-10-26 2002-05-02 Genopoietic Synthetische Viren und ihre Verwendungen
DE102007020895B3 (de) * 2007-05-04 2008-08-07 Dräger Safety AG & Co. KGaA Vorrichtung zur Aufnahme von Flüssigkeitsproben
CA2838749A1 (en) * 2011-06-10 2012-12-13 Bluebird Bio, Inc. Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
CN104884627A (zh) 2012-10-25 2015-09-02 托卡根公司 具有小型启动子盒的逆转录病毒载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03492B1 (et) * 1994-09-02 2001-08-15 GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid
US6228646B1 (en) * 1996-03-07 2001-05-08 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
AU728610B2 (en) * 1996-11-19 2001-01-11 University Of Alabama At Birmingham Research Foundation Chimeric retrovirus/adenovirus system

Also Published As

Publication number Publication date
CA2332639A1 (fr) 1999-11-25
AU762973B2 (en) 2003-07-10
AU3829399A (en) 1999-12-06
FR2778670A1 (fr) 1999-11-19
NZ508791A (en) 2003-09-26
US6489142B1 (en) 2002-12-03
WO1999060144A1 (fr) 1999-11-25
EP1078094B1 (de) 2010-07-07
EP1078094A1 (de) 2001-02-28
JP2002539758A (ja) 2002-11-26
DE69942564D1 (de) 2010-08-19
FR2778670B1 (fr) 2002-12-13

Similar Documents

Publication Publication Date Title
DE60024302D1 (de) Zelllinien und konstrukte für die herstellung von e1-deletierten adenoviren in abwesenheit von replikationskompetentem adenovirus
NZ509633A (en) A recombinant chimeric PEG-uricase with a long circulatory life and reduced immunogenicity
WO1999011764A3 (en) Methods for generating high titer helper-free preparations of recombinant aav vectors
DE69534669D1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
HUP0003331A2 (hu) Eljárás a C-szerocsoportba nem besorolható adenovirális vektorok előállítására
ATE291633T1 (de) Rekombinante adenovirale vektoren, die chimäre fiberproteine exprimieren, für die zellspezifische infektion und genomische integration
DE59913833D1 (de) Strukturprotein von aav, seine herstellung und verwendung
DE69932599D1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
ATE526818T1 (de) Gentechnisch hergestellte wasserlinse
DE69942564D1 (de) Methoden und zusammensetzungen für die produktion von viruspartikeln
CA2306449A1 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
DE69716581T2 (de) Retroviraler vektor und dessen verwendung in gentherapie
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
DE69535024D1 (de) Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren
ATE355385T1 (de) Herstellung von rekombinanten adenoviren und von adenovirus-genbanken
CO4790179A1 (es) Procedimiento para la fabricacion de proteinas humanas por activacion genica endogena
WO2000053759A8 (en) Expression of human alpha-fetoprotein in mammalian cells
EP0843006A3 (de) Rekombinante prostataspezifische Antigen-Vektoren und diese verwendende Assays
AU4216599A (en) Hematopoietic progenitor cell gene transduction

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties